Cymbalta (Duloxetine) Half-Life: How Long It Stays in Your Body

Natalie Watkins
Dr. Jennie Stanford
Written by Natalie Watkins on 01 April 2025
Medically reviewed by Dr. Jennie Stanford on 01 April 2025

Cymbalta is an antidepressant used to treat anxiety, major depressive disorder, and pain for some patients. It is the brand name for the generic drug duloxetine.

Cymbalta is an SNRI (serotonin norepinephrine reuptake inhibitor), which means that it increases the amount of serotonin and norepinephrine found in the brain. It is slow-acting, and it can take days or weeks to have a noticeable effect.

Cymbalta is not a common drug of abuse and is not regularly included on drug tests. It is typically passed out of the body through urine within 5 days, but some traces can be found in hair follicles for significantly longer.

This table shows how long after use Cymbalta can be detected by different drug tests.

Drug sample typeCymbalta detection time
UrineCan last up to 5 days, but no urine tests are currently available
Blood2-3 days
SalivaNo saliva tests currently available
Hair90 days after use
Key takeaways:
  • Cymbalta is an antidepressant that is rarely included on routine drug tests.
  • Cymbalta takes around 6 hours after each dose to reach maximum concentration in the blood. It builds up with regular use to reach a steady state.
  • It’s not recommended that patients stop taking Cymbalta suddenly, as this can lead to withdrawal effects.
a photo of an entire pill bottle with the label Cymbalta on it

Cymbalta half-life: How long it takes duloxetine to clear from the body

Cymbalta has an elimination half life of 10-12 hours, although this can vary between individuals. This means that half the amount of Cymbalta in the bloodstream is cleared from the body within 10-12 hours. If no more of the drug is taken, half the remaining Cymbalta will be removed over the periods of 10-12 hours until it has all been eliminated.

It typically takes 5 or 6 half-lives for a drug to be fully removed from the blood. In the case of Cymbalta, this is approximately 72 hours or 3 days.

Duration of therapeutic effects

Because Cymbalta is vulnerable to acids, tablets and capsules are coated in a substance that protects the medication until it has passed through the stomach. This means that it takes about two hours after taking the drug before it starts to be absorbed. This can be delayed by several hours if the tablet is taken with a large meal or at bedtime.

Duloxetine typically reaches peak plasma concentration approximately 6 hours after taking a tablet. It usually takes approximately 3 days of regularly using Cymbalta to reach a consistent level of duloxetine in the blood. It can take several weeks to feel the therapeutic effects, however.

Cymbalta detection in drug tests

Cymbalta isn’t regularly included on standard 5- or 10-panel drug tests because it is not listed as a controlled substance or considered a drug of abuse. It also has accepted therapeutic purposes, meaning that employers should not consider the presence of Cymbalta a cause for concern.

Urine testing

72% of Cymbalta is excreted in urine, meaning that it can show up on specialized urine tests. There are no urine tests for Cymbalta currently available, however. If such tests were available, they would be expected to detect Cymbalta up to 5 days after the last dose.

Blood testing

Cymbalta is found in the blood for up to three days, but blood tests for levels of Cymbalta are not routinely carried out.

Saliva testing

There are no currently available saliva tests for Cymbalta. Saliva tests are most commonly used by law enforcement or in crisis situations to detect whether someone is currently under the influence of a drug. This wouldn’t normally be a concern for Cymbalta.

Hair testing

As with most other drugs, Cymbalta can be detected in hair follicles for a significant period of time after ingestion, usually around 90 days. These tests can show the pattern and duration of use but they are rarely performed.

Factors affecting cymbalta detection

Cymbalta elimination can be faster or slower for particular patients, but these differences are relatively minor.

Men typically have shorter elimination times than women, and smokers will often have shorter elimination times than non-smokers. Similarly, older people will usually take slightly longer to remove Cymbalta from their systems than younger people.

Practical guidelines before stopping Cymbalta

Stopping Cymbalta suddenly can lead to unpleasant withdrawal effects. The FDA recommends reducing dosage slowly to minimize these symptoms, although this doesn’t eliminate the possibility of experiencing withdrawal symptoms.

When stopping Cymbalta, potential withdrawal symptoms can include dizziness, headaches, and strange tingling sensations that feel like electric shocks (paresthesias).

It is imperative for individuals to discuss with their doctor before reducing or stopping Cymbalta. They should also contact their doctor again if withdrawal symptoms occur, especially if they are becoming difficult to cope with. Individuals may need to adjust how quickly they reduce their dosage or consider other medications to reduce the effects.

FAQs

Common questions about Cymbalta

What is duloxetine and what is it for?

Duloxetine is the generic name for Cymbalta, an SNRI antidepressant that can be used to treat depression, anxiety, and certain forms of long-term pain.

What are the side effects of Cymbalta?

Common side effects of Cymbalta include nausea, headache, dry mouth, drowsiness, fatigue, insomnia, and diarrhea. More serious side effects, such as serotonin syndrome, liver failure, or manic episodes, are rare.

Can I suddenly stop taking Cymbalta?

Doctors recommend not stopping taking Cymbalta suddenly, as it can lead to unpleasant withdrawal effects, including dizziness, headaches, and unpleasant tingling sensations. You would normally reduce Cymbalta intake slowly unless there is a medical emergency that requires immediate cessation.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. FDA. (n.d.). Cymbalta. In .
  2. Bonilla-Jaime, H., Sánchez-Salcedo, J. A., Estevez-Cabrera, M. M., Molina-Jiménez, T., Cortes-Altamirano, J. L., & Alfaro-Rodríguez, A. (2022). Depression and Pain: Use of Antidepressants. Current neuropharmacology, 20(2), 384–402.
  3. Knadler, M. P., Lobo, E., Chappell, J., & Bergstrom, R. (2011). Duloxetine. Clinical Pharmacokinetics, 50(5), 281–294.
  4. National Center for Biotechnology Information (2025). PubChem Compound Summary for CID 60835, Duloxetine. Retrieved March 4, 2025 from
  5. Detke, M. J., Wiltse, C. G., Mallinckrodt, C. H., McNamara, R. K., Demitrack, M. A., & Bitter, I. (2004). Duloxetine in the acute and long-term treatment of major depressive disorder: A placebo- and paroxetine-controlled trial. European Neuropsychopharmacology, 14(6), 457–470.
  6. Rodrigues-Amorim, D., Olivares, J. M., Spuch, C., & Rivera-Baltanás, T. (2020). A systematic review of efficacy, safety, and tolerability of duloxetine. Frontiers in Psychiatry, 11(1), 554899.
  7. Pergolizzi, J. V., Jr, Raffa, R. B., Taylor, R., Jr, Rodriguez, G., Nalamachu, S., & Langley, P. (2013). A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain practice : the official journal of World Institute of Pain, 13(3), 239–252.

Activity History - Last updated: 01 April 2025, Published date:


Reviewer

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Jennie Stanford, MD, FAAFP, DipABOM is a dual board-certified physician in both family medicine and obesity medicine. She has a wide range of clinical experiences, ranging from years of traditional clinic practice to hospitalist care to performing peer quality review to ensure optimal patient care.

Activity History - Medically Reviewed on 31 March 2025 and last checked on 01 April 2025

Medically reviewed by
Dr. Jennie Stanford

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (855) 648-7288
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org

Related guides

Types of Drug Tests

4 minutes read